Dr. Reddy’s Q1FY25 Financial Results
Hyderabad, India, July 29, 2024: Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter ended June 30, 2024. The information mentioned in this release is based…
Aurigene Pharma Services Unveils New Biologics Facility for Process Development and Clinical Manufacturing
Hyderabad, India- June 04, 2024: Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster,…
Dr. Reddy’s enters into exclusive distribution partnership with Sanofi Healthcare India Private Limited for their vaccine brands in India
Hyderabad India; March 28, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced…